Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?4.0 RB, SLActive? 10mm, RXD: medical device reports filed with FDA

7,121 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

7,121
device reports naming the brand
0% of all MAUDE reports · about 1,043 a year
1,709
reports, 12 months to August 2026
1,723 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 7,121 reports that name the brand "BLX ?4.0 RB, SLActive? 10mm, RXD" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

1,709 reports arrived in the 12 months to August 2026, close to the 1,723 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (69.6%), loss of osseointegration (17.2%) and difficult to insert (1.4%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0214428Sep 2021: 52Oct 2021: 51Nov 2021: 63Dec 2021: 532022Jan 2022: 51Feb 2022: 49Mar 2022: 63Apr 2022: 53May 2022: 84Jun 2022: 75Jul 2022: 67Aug 2022: 74Sep 2022: 81Oct 2022: 79Nov 2022: 84Dec 2022: 1072023Jan 2023: 76Feb 2023: 103Mar 2023: 101Apr 2023: 119May 2023: 107Jun 2023: 98Jul 2023: 76Aug 2023: 97Sep 2023: 91Oct 2023: 90Nov 2023: 99Dec 2023: 1302024Jan 2024: 88Feb 2024: 85Mar 2024: 100Apr 2024: 110May 2024: 132Jun 2024: 127Jul 2024: 121Aug 2024: 121Sep 2024: 152Oct 2024: 162Nov 2024: 176Dec 2024: 1452025Jan 2025: 99Feb 2025: 117Mar 2025: 165Apr 2025: 61May 2025: 0Jun 2025: 428Jul 2025: 95Aug 2025: 123Sep 2025: 100Oct 2025: 146Nov 2025: 122Dec 2025: 1622026Jan 2026: 112Feb 2026: 121Mar 2026: 147Apr 2026: 127May 2026: 133Jun 2026: 178Jul 2026: 181Aug 2026: 180

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

08091,6182019: 1820192020: 21820202021: 51520212022: 86720222023: 1,18720232024: 1,51920242025: 1,61820252026: 1,1792026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%7,121
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report77.9%5,546
Voluntary report0%0
User facility report0%0
Distributor report22.1%1,575
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate4,95969.6%62.8%
Loss of osseointegration1,22217.2%22.4%
Difficult to insertthe device was hard to insert1011.4%0.4%
Fracturea broken bone350.5%1.6%
Separation failure190.3%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis2,55735.9%
Painpain, site not specified1,51621.3%
Inflammationinflammation4005.6%
Hemorrhage/blood loss/bleeding2924.1%
Swelling/ edema2844%
Hyperresponsive to stimuli2273.2%
Fistula1351.9%
Abscessa collection of pus1251.8%
Tissue damage1181.7%
Hypersensitivity/allergic reaction731%
Sinus perforation490.7%
Numbnessnumbness210.3%
Failure of implant130.2%
Inadequate osseointegration80.1%
Increased sensitivity60.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?4.0 RB, SLActive? 10mm, RXDProduct code DZEAll MAUDE reports
Reports7,1213,924,24126,136,888
Share of that pool—0.2%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer77.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?4.0 RB, SLActive? 10mm, RXD reports

How many FDA reports name BLX ?4.0 RB, SLActive? 10mm, RXD?

7,121 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,709 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (69.6%), loss of osseointegration (17.2%), difficult to insert (1.4%), fracture (0.5%) and separation failure (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (77.9%) and distributor reports (22.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?4.0 RB, SLActive? 10mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.